- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Global Healthcare Summit 2017 | 31 December, 2017
REVA PHARMA was represented by Dr Gurpreet Sandhu at the CEO FORUM “Global Healthcare Summit 2017†organized by AAPI (American Association Physicians of Indian Origin). The event took place on 30th December 2017 at Kolkata (India). AAPI is a non-profit U.S. organization working for betterment of patients. The body comprises of over 100,000 (Medical Doctors) working in the United States. The organization is committed towards offering healthcare services to India.
The event was the 6th Healthcare Leadership session conducted by AAPI in conjunction with Ministry of Health & Ministry of Commerce (India). The forum was represented by CEO’s and Industry leaders from Healthcare, Pharma besides experts from United States, Canada and United Kingdom.
Dr Sandhu in his address gave his vision & direction related to ACCESS to HEALTHCARE. He expressed the drivers which need to be practiced for building Medical Services & Healthcare in India.